PubMed: Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review
Front Pharmacol. 2023 Jan 23;14:1094020. doi: 10.3389/fphar.2023.1094020. eCollection 2023.
Cannabidiol (CBD) is a terpenoid naturally found in plants. The purified compound is used in the treatment of mental disorders because of its antidepressive, anxiolytic, and antiepileptic effects. CBD can affect the regulation of several pathophysiologic processes, including autophagy, cytokine secretion, apoptosis, and innate and adaptive immune responses. However, several authors have reported contradictory findings concerning the magnitude and direction of CBD-mediated effects. For example, CBD treatment can increase, decrease, or have no significant effect on autophagy and apoptosis. These variable results can be attributed to the differences in the biological models, cell types, and CBD concentration used in these studies. This review focuses on the mechanism of regulation of autophagy and apoptosis in inflammatory response and cancer by CBD. Further, we broadly elaborated on the prospects of using CBD as an anti-inflammatory agent and in cancer therapy in the future.
PMID:36755953 | PMC:PMC9899821 | DOI:10.3389/fphar.2023.1094020
https://pubmed.ncbi.nlm.nih.gov/36755953/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1NqsX9BbHlDygQ8TcgAlJilHgPpiuKQtyIr–a3-xbLzPoB9xM&fc=20220928170152&ff=20230209152322&v=2.17.9.post6+86293ac February 9, 2023 11:00 am